Edition:
United States

Helius Medical Technologies Inc (HSM.TO)

HSM.TO on Toronto Stock Exchange

3.00CAD
24 Nov 2017
Change (% chg)

$-0.10 (-3.23%)
Prev Close
$3.10
Open
$3.11
Day's High
$3.20
Day's Low
$3.00
Volume
127,580
Avg. Vol
168,122
52-wk High
$5.09
52-wk Low
$1.72

Latest Key Developments (Source: Significant Developments)

Helius Medical Technologies provides clarification on clinical trial results
Friday, 17 Nov 2017 08:43am EST 

Nov 17 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA.  Full Article

Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury
Thursday, 9 Nov 2017 06:00am EST 

Nov 9 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury (TBI).  Full Article

Helius Medical Technologies files for mixed shelf of up to $100 mln - SEC filing
Friday, 23 Dec 2016 06:22am EST 

Helius Medical Technologies Inc : Files for mixed shelf of up to $100 million - SEC filing .May use a portion of net proceeds to invest,acquire businesses,technologies we believe are complementary.  Full Article

Helius Medical reached full enrollment in tactile communication and neurorehabilitation laboratory clinical trial
Monday, 5 Dec 2016 09:00am EST 

Helius Medical Technologies Inc : Full enrollment reached in tactile communication and neurorehabilitation laboratory clinical trial .Helius Medical Technologies Inc says based on treatment timeline, expected completion date of 44-subject study for PoNS therapy is late May, 2017.  Full Article

Helius Medical Technologies, Inc announces pricing of unit offering
Thursday, 24 Mar 2016 07:54am EDT 

Helius Medical Technologies, Inc:Says Co at price of C$1.00 per Unit for gross proceeds of a minimum of C$8 million and up to a maximum of C$20 million.Says each Unit is priced at C$1.00 and consists of one Class A common share in the capital of the Company.Closing of the Offering is expected to occur on or about April 5, 2016, or in any event, no later than June 17, 2016.  Full Article

BRIEF-Helius Medical Technologies provides clarification on clinical trial results

* Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA Source text for Eikon: Further company coverage:

No consensus analysis data available.